PUBLICATION
Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells
- Authors
- Palano, M.T., Giannandrea, D., Platonova, N., Gaudenzi, G., Falleni, M., Tosi, D., Lesma, E., Citro, V., Colombo, M., Saltarella, I., Ria, R., Amodio, N., Taiana, E., Neri, A., Vitale, G., Chiaramonte, R.
- ID
- ZDB-PUB-201002-68
- Date
- 2020
- Source
- Cancers 12(9): (Journal)
- Registered Authors
- Keywords
- Jagged, Notch, VEGF, angiogenesis, bone marrow stromal cells, multiple myeloma
- MeSH Terms
- none
- PubMed
- 32932949 Full text @ Cancers
Citation
Palano, M.T., Giannandrea, D., Platonova, N., Gaudenzi, G., Falleni, M., Tosi, D., Lesma, E., Citro, V., Colombo, M., Saltarella, I., Ria, R., Amodio, N., Taiana, E., Neri, A., Vitale, G., Chiaramonte, R. (2020) Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells. Cancers. 12(9):.
Abstract
Multiple myeloma (MM) is an incurable plasma cell malignancy arising primarily within the bone marrow (BM). During MM progression, different modifications occur in the tumor cells and BM microenvironment, including the angiogenic shift characterized by the increased capability of endothelial cells to organize a network, migrate and express angiogenic factors, including vascular endothelial growth factor (VEGF). Here, we studied the functional outcome of the dysregulation of Notch ligands, Jagged1 and Jagged2, occurring during disease progression, on the angiogenic potential of MM cells and BM stromal cells (BMSCs). Jagged1-2 expression was modulated by RNA interference or soluble peptide administration, and the effects on the MM cell lines' ability to induce human pulmonary artery cells (HPAECs) angiogenesis or to indirectly increase the BMSC angiogenic potential was analyzed in vitro; in vivo validation was performed on a zebrafish model and MM patients' BM biopsies. Overall, our results indicate that the MM-derived Jagged ligands (1) increase the tumor cell angiogenic potential by directly triggering Notch activation in the HPAECs or stimulating the release of angiogenic factors, i.e., VEGF; and (2) stimulate the BMSCs to promote angiogenesis through VEGF secretion. The observed pro-angiogenic effect of Notch activation in the BM during MM progression provides further evidence of the potential of a therapy targeting the Jagged ligands.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping